CMB 1.28% 38.5¢ cambium bio limited

RGSH4K is also undergoing pre-clinical trials with an anti-pd1...

  1. 5,133 Posts.
    lightbulb Created with Sketch. 44
    RGSH4K is also undergoing pre-clinical trials with an anti-pd1 inhibitor for combination therapy.These results should be available in the near future too.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.